The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on Monday, December 9, 2013. The agenda for the meeting is as follows:
Morning Session
• Meet and Greet (8:30 - 9:00 am ET) -- Wanda Walker, Jerry Lorengo, and James Wilson (Acting), Directors, TC1600 SPEs
• Opening Remarks (9:00 - 9:30 am): Bruce Kisliuk, Deputy Commissioner for Patent Administration
• BCP Website (9:30 - 9:35 am): Suzannah K. Sundby of Gambrell & Russell, LLP, Chair of the Biotech Committee of the AIPLA
• Making a Prima Facie Case (in Polymorph Cases) (9:35 - 10:30 am): Bennett Celsa, QAS, TC1600 & Janet Andreas, SPE, Art Unit 1625
• Break (10:30 - 10:45 am)
• Developments in the Patent Prosecution Highway (PPH) (10:45 - 11:45 am): Mark Powell, Special Advisor to the Commissioner for Patent
• Lunch (11:45 – 1:30 pm)
Afternoon Session
• Two Recent Supreme Court Cases: Bowman v. Monsanto and Association for Molecular Pathology v. Myriad Genetics (1:30 - 2:30 pm): Roberte Makowski, Ph.D., J.D., Senior Counsel, BASF
• Closing Remarks/Discussion (2:30 - 2:45 pm): Wanda Walker, Jerry Lorengo, and James Wilson (Acting), Directors, TC1600 SPEs
The meeting can be viewed online here. Additional information regarding the BCP customer partnership meeting, including instructions for viewing the meeting online, can be found here.
Comments